JPMorgan’s (JPM) 43rd Annual Healthcare Conference kicked off Monday in San Francisco and will continue through January 16, 2025. Yahoo Finance Senior Health Reporter Anjalee Khemlani analyzes key themes from the event, including artificial intelligence developments and major acquisitions.
Notable among these is the $14.6 billion deal between Johnson & Johnson (JNJ) and Intra-Cellular Therapies (ITCI).
To watch more expert insights and analysis on the latest market action, check out more Market Domination here.
This post was written by Angel Smith
